Letter

Direct to consumer advertising

A cynical consultation exercise?

BMJ 2008; 336 doi: 10.1136/bmj.39542.489329.BE (Published 10 April 2008)
Cite this as: BMJ 2008;336:787.2

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

  1. Charles Medawar, medicines policy analyst
  1. 1Social Audit, PO Box 111, London NW1 8XG
  1. charles{at}socialaudit.org.uk

    The dismal proposals to allow pharmaceutical companies to promote prescription drugs directly to consumers have been orchestrated by the European Commission’s Directorate General for Enterprise and Industry (DGEI).1

    The DGEI’s main objective is to promote European trade and economic development, which presents grotesque conflicts of interest when it comes to shaping health policy. DGEI greatly overestimates the support …

    Access to the full text of this article requires a subscription or payment

    Subscribe

    Article access

    Article access for 1 day

    Purchase this article for £20 $30 €32*

    The PDF version can be downloaded as your personal record

    * Prices do not include VAT

    Rapid responses

    THIS WEEK'S POLL

    BMJ most popular